Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

AIM: Anticoagulation prophylaxis for stroke is recommended for at-risk patients with either persistent or paroxysmal atrial fibrillation (AF). We compared outcomes in patients with persistent vs. paroxysmal AF receiving oral anticoagulation. METHODS AND RESULTS: Patients randomized in the Rivaroxaba...

詳細記述

保存先:
書誌詳細
出版年:Eur Heart J
主要な著者: Steinberg, Benjamin A., Hellkamp, Anne S., Lokhnygina, Yuliya, Patel, Manesh R., Breithardt, Günter, Hankey, Graeme J., Becker, Richard C., Singer, Daniel E., Halperin, Jonathan L., Hacke, Werner, Nessel, Christopher C., Berkowitz, Scott D., Mahaffey, Kenneth W., Fox, Keith A.A., Califf, Robert M., Piccini, Jonathan P.
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2015
主題:
Clinical Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4313363/
https://ncbi.nlm.nih.gov/pubmed/25209598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehu359
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料